ArticleJournal of diabetes and metabolic disorders2025
Type 5 diabetes as a growing malnutrition driven health crisis in low and middle income countries.
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Type 5 Diabetes Mellitus: Pathophysiology, Clinical Phenotype, and Nutritional Management.Diabetes/metabolism research and reviews · 2026Review
- Article
- Decoding type 5 diabetes using spatial omics: microarchitectural and molecular mechanisms of malnutrition-associated diabetes.Frontiers in endocrinology · 2026Review
- Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review.Frontiers in immunology · 2025Review
- Type 5 diabetes mellitus: redefining pancreatogenic diabetes through molecular, imaging, and AI-driven evidence.Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type 5 diabetes mellitus (T5DM), recently redefined as malnutrition-related diabetes, represents a distinct form of severe insulin-deficient diabetes that arises from chronic undernutrition, particularly during childhood and adolescence. Unlike type 1 and type 2 diabetes, T5DM is neither autoimmune-mediated nor primarily driven by insulin resistance. Instead, it results from impaired pancreatic development and disrupted insulin signaling pathways due to prolonged nutritional deficiencies. This commentary proposes the formal adoption of "malnutrition-related diabetes" as the nomenclature for T5DM to more accurately reflect its etiology and clinical features. The condition is disproportionately prevalent in low and middle income countries, where malnutrition remains widespread and access to advanced diabetes care is limited. Accurate recognition and classification of T5DM are critical for developing appropriate diagnostic criteria, management strategies, and public health policies. Treatment typically focuses on nutritional rehabilitation and cost-effective oral antidiabetic therapies, rather than insulin dependence. Establishing malnutrition-related diabetes as a distinct category will support targeted research, improve patient outcomes, and raise awareness of its growing burden in vulnerable populations. This commentary urges the global health community to recognize malnutrition-related diabetes as a pressing metabolic disorder requiring urgent attention in low resource settings. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-025-01674-w.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.